| 摘要 |
Method for detecting presence, or risk of developing, encephalopathy in mammals, from presence of specific markers. Method for detecting presence, or risk of developing, encephalopathy in mammals comprises determining, in a biological sample, at least one of the following targets: (a) nucleic acid (NA), i.e. any of 22 sequences reproduced, or their fragments with at least 5, preferably 6-10, consecutive bases; (b) the complements of (a); (c) functional analogs of NA or its complements, derived from another species or a natural variant; or (d) a polypeptide (PP) encoded by (a)-(c). Independent claims are also included for the following: (1) product containing at least one NA, or its fragment, complement or functional analog, immobilized on a support; (2) product containing at least one PP encoded by NA, its fragments of at least 15 bases, complements or functional analogs; and (3) kits that contain NA, or its fragments, complements or functional analogs. |
